M.D. Sass LLC’s Gildan GIL Stock Holding History

M.D. Sass LLC’s Portfolio GIL Stock Details GIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.1M	Buy	+396,504	New	+$25.6M	1.67%	23
2020 Q1	–	Sell	-533,232	Closed	-$15.7M	–	41
2019 Q4	$15.7M	Buy	533,232 +124,814	+31%	+$3.65M	3.73%	8
2019 Q3	$14.5M	Sell	408,418 -47,515	-10%	-$1.79M	3.42%	8
2019 Q2	$17.6M	Sell	455,933 -334,415	-42%	-$12.5M	4.08%	5
2019 Q1	$28.4M	Sell	790,348 -146,031	-16%	-$5M	4.53%	4
2018 Q4	$28.4M	Sell	936,379 -17,269	-2%	-$533K	4.83%	2
2018 Q3	$29M	Buy	+953,648	New	+$27.7M	3.83%	9

Other funds holding GIL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

M.D. Sass LLC's GIL Position: Q1 2026 in Review

M.D. Sass LLC opened a new position in Gildan (GIL) in Q1 2026: 396,504 shares worth $22.1M. The stake represents 1.67% of the portfolio and ranks #23 among its holdings. This is a return to the name: M.D. Sass LLC previously reported a position in GIL as recently as Q4 2019.

M.D. Sass LLC first reported a position in GIL in Q3 2018 and has held it in 7 quarters since. The position peaked at $29M in Q3 2018. 482 funds tracked by Wall St. Rank hold GIL as of Q1 2026.

M.D. Sass LLC held 396,504 shares of Gildan worth $22.1M as of Q1 2026.
Gildan was a new M.D. Sass LLC position in Q1 2026.
Gildan made up 1.67% of M.D. Sass LLC's portfolio in Q1 2026, its #23 holding.
M.D. Sass LLC first reported a position in Gildan in Q3 2018 and has held it in 7 quarters since.
M.D. Sass LLC's Gildan position peaked at $29M in Q3 2018.
482 funds tracked by Wall St. Rank held Gildan as of Q1 2026.

Based on M.D. Sass LLC's 13F filing for Q1 2026, filed 14 May 2026.